Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RD13-01 for Patients With r/r CD7+ T/NK Cell Hematologic Malignancies

NCT04538599 is registered in ClinicalTrials.gov with He Huang as lead sponsor.

NCT NCT04538599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04538599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RD13-01 for Patients With r/r CD7+ T/NK Cell Hematologic Malignancies
Lead sponsor
He Huang
Phase
Phase 1
Overall status
Completed
Start date
September 10, 2020
Completion date
November 30, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancies